Taiwan's Medigen Vaccine Biologics Corp. is accelerating a Phase 3 clinical trial in Paraguay for its COVID-19 vaccine, with the trial expected to produce key safety and efficacy data during the fourth quarter of this year, the company said Wednesday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Business
Major renovations begin on Green Island, Orchid Island airports
05/20/2025 05:03 PM - Business
U.S. dollar closes lower on Taipei forex market
05/20/2025 04:15 PM - Politics
President Lai calls for opposition talks as political discord grows
05/20/2025 04:12 PM - Sports
Pilots even series with Braves, set up first Game 7 in PLG finals
05/20/2025 03:53 PM - Politics
Taiwan regrets over no invitation to Nagasaki atomic bomb memorial
05/20/2025 02:36 PM